Hereditary Insights into Oxygen Sensing and Cancer: The von Hippel-Lindau Cancer Syndrome
November 9, 2018
This activity will provide Duke medical alumni with relevant, timely, and useful information who are at the forefront in their respective fields in research for health care and teaching.
Target Audience
All physicians,
Learning Objectives
Illustrate how studies of von Hippel-Lindau disease led to our current understanding of how metazoans, including man, sense and respond to changes in oxygen availability via the transcription factor HIF (Hypoxia-Inducible Factor).
Durham, NC
United States
Available Credit
- 1.00 AMA PRA Category 1 Credit(s)™
- 1.00 Attendance